ZA972837B - Spray-dried microparticles as therapeutic vehicles for use in gene therapy. - Google Patents

Spray-dried microparticles as therapeutic vehicles for use in gene therapy.

Info

Publication number
ZA972837B
ZA972837B ZA9702837A ZA972837A ZA972837B ZA 972837 B ZA972837 B ZA 972837B ZA 9702837 A ZA9702837 A ZA 9702837A ZA 972837 A ZA972837 A ZA 972837A ZA 972837 B ZA972837 B ZA 972837B
Authority
ZA
South Africa
Prior art keywords
spray
gene therapy
dried microparticles
therapeutic vehicles
therapeutic
Prior art date
Application number
ZA9702837A
Other languages
English (en)
Inventor
Andrew Derek Sutton
Jill Elizabeth Ogden
Richard Alan Johnson
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andaris Ltd filed Critical Andaris Ltd
Publication of ZA972837B publication Critical patent/ZA972837B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA9702837A 1996-04-03 1997-04-03 Spray-dried microparticles as therapeutic vehicles for use in gene therapy. ZA972837B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9607035.4A GB9607035D0 (en) 1996-04-03 1996-04-03 Spray-dried microparticles as therapeutic vehicles
GB9601379 1996-06-07

Publications (1)

Publication Number Publication Date
ZA972837B true ZA972837B (en) 1998-04-03

Family

ID=26308516

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9702837A ZA972837B (en) 1996-04-03 1997-04-03 Spray-dried microparticles as therapeutic vehicles for use in gene therapy.

Country Status (14)

Country Link
EP (1) EP0936902B1 (enExample)
JP (1) JP2000507568A (enExample)
AR (1) AR007493A1 (enExample)
AT (1) ATE243027T1 (enExample)
AU (1) AU715512B2 (enExample)
CA (1) CA2250478A1 (enExample)
DE (1) DE69722952T2 (enExample)
DK (1) DK0936902T3 (enExample)
ES (1) ES2201283T3 (enExample)
GB (1) GB9607035D0 (enExample)
NO (1) NO984462D0 (enExample)
PT (1) PT936902E (enExample)
WO (1) WO1997036578A1 (enExample)
ZA (1) ZA972837B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
DE69608122T3 (de) 1995-11-09 2011-06-16 Microbiological Research Authority Camr, Salisbury Mikroverkapselte dna zur impfung und gentherapie
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6406719B1 (en) 1998-05-13 2002-06-18 Microbiological Research Authority Encapsulation of bioactive agents
GB9810236D0 (en) 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents
AU6124601A (en) 2000-05-10 2001-11-20 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7575761B2 (en) 2000-06-30 2009-08-18 Novartis Pharma Ag Spray drying process control of drying kinetics
WO2002015880A2 (en) * 2000-08-25 2002-02-28 Merck Patent Gmbh Powdered mannitol and mannitol-containing compositions
KR100958235B1 (ko) 2001-12-19 2010-05-17 노바르티스 아게 아미노글리코시드의 폐 전달
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
EP1758558B1 (en) 2004-05-12 2013-10-16 Baxter International Inc. Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
US7815941B2 (en) 2004-05-12 2010-10-19 Baxter Healthcare S.A. Nucleic acid microspheres, production and delivery thereof
EP1834651A1 (en) * 2006-03-15 2007-09-19 Universiteit Gent Compositions and methods for veterinary vaccination
MX2009001226A (es) 2006-08-04 2009-03-20 Baxter Int Composicion basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nuevo inicio.
US8808747B2 (en) 2007-04-17 2014-08-19 Baxter International Inc. Nucleic acid microparticles for pulmonary delivery
DE102009033196A1 (de) * 2009-07-14 2011-01-20 Beiersdorf Ag Kosmetische Zubereitung mit einem Gehalt an dispergierten Mikrosphären
CN120514877A (zh) * 2018-07-23 2025-08-22 川斯勒佰尔公司 信使rna的干粉制剂
WO2020145872A1 (en) * 2019-01-09 2020-07-16 Ziccum Ab Stabilized non-enveloped virus compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
KR100277622B1 (ko) * 1992-06-12 2001-01-15 이타가키 히로시 흡입용 초미립자 분말 및 그의 제조방법
US5626871A (en) * 1992-06-12 1997-05-06 Teijin Limited Preparation for intratracheobronchial administration
NZ265555A (en) * 1993-04-19 1997-09-22 Medisorb Technologies Internat Biodegradable microparticle compositions of antisense oligodeoxyribonucleotides
EP0759939B1 (en) * 1994-05-18 2005-07-20 Nektar Therapeutics Methods and compositions for the dry powder formulation of interferons
EP0783298A1 (en) * 1994-09-29 1997-07-16 Andaris Limited Spray-dried microparticles as therapeutic vehicles
WO1996027393A1 (en) * 1995-03-07 1996-09-12 University Of Pittsburgh A dry powder formulation for gene therapy
EP0840623B1 (en) * 1995-07-21 2007-07-18 Brown University Research Foundation Compositions for gene therapy comprising nucleic acid loaded polymeric microparticles

Also Published As

Publication number Publication date
AR007493A1 (es) 1999-11-10
AU715512B2 (en) 2000-02-03
DK0936902T3 (da) 2003-10-06
ES2201283T3 (es) 2004-03-16
DE69722952T2 (de) 2003-12-11
ATE243027T1 (de) 2003-07-15
DE69722952D1 (de) 2003-07-24
NO984462L (no) 1998-09-25
NO984462D0 (no) 1998-09-25
AU2302097A (en) 1997-10-22
CA2250478A1 (en) 1997-10-09
JP2000507568A (ja) 2000-06-20
EP0936902B1 (en) 2003-06-18
EP0936902A1 (en) 1999-08-25
GB9607035D0 (en) 1996-06-05
PT936902E (pt) 2003-11-28
WO1997036578A1 (en) 1997-10-09

Similar Documents

Publication Publication Date Title
ZA972837B (en) Spray-dried microparticles as therapeutic vehicles for use in gene therapy.
ZA958239B (en) Spray-dried microparticles as therapeutic vehicles
MXPA02002898A (es) Pirazolopirimidinas como agentes terapeuticos.
GB9622500D0 (en) Therapeutic gene
AU9262598A (en) Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders
ZA987844B (en) Therapeutic combinations.
GB0017362D0 (en) Defibrillation system
AU2222800A (en) Improved cooling/heating pad and system
ZA9711029B (en) Therapeutic agents.
AU2637100A (en) Delivery system and methods for gene therapy
GB9621825D0 (en) Microparticles and their use as therapeutic vehicles
AU7795500A (en) Peptides which stimulate the immune response and tissue regeneration
AU5298699A (en) Dnazymes and methods for treating hpv-related disorders
HUP0002329A3 (en) New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy
AU6692300A (en) Tankyrase homolog protein (thp), nucleic acids, and methods related to the same
ZA991783B (en) Therapeutic treatment for autoimmune diseases.
GB0025890D0 (en) Gene therapy
GB9900009D0 (en) Gene therapy
AU7262800A (en) Diagnostic and therapeutic methods in autoimmune disease
GB0406539D0 (en) Gene therapy
GB2388323B (en) Defibrillation system
GB2333527B (en) Therapeutic gene
PL105002U1 (en) Therapeutic cushion
ZA951451B (en) Host vector system for use in gene therapy
GB9920837D0 (en) Gene therapy